Keyword Connections

pembrolizumab

Journals

3

1 Asia-Pacific journal of oncology nursing

2 OncoTargets and therapy

3 biomedicine hub

Research Groups

0

No Research Group Connected

Bibliographies

18

1 The FDA Changed Everything.

2 pembrolizumab activity in recurrent high-grade gliomas with partial or complete loss of mismatch repair protein expression: a monocentric, observational and prospective pilot study

3 pulmonary sarcoidosis activation following neoadjuvant pembrolizumab plus chemotherapy combination therapy in a patient with non-small cell lung cancer: a case report

4 Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors

5 Immune-Related Adverse Events in the Older Adult with Cancer Receiving Immune Checkpoint Inhibitor Therapy.

6 The Combined Use of Chemotherapy and Radiotherapy with PD-1 Inhibitor, Pembrolizumab, in Advanced Cervical Cancer: A Case Report.

7 Initial Experience of Pembrolizumab Therapy in Japanese Patients With Metastatic Urothelial Cancer.

8 A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer.

9 Cost-effectiveness analysis of pembrolizumab compared to standard of care as first line treatment for patients with advanced melanoma in Hong Kong.

10 Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practice

11 Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial

12 Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas.

13 pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives

14 Frontline pembrolizumab for the treatment of RET-rearranged non-small cell lung cancer: A case report

15 The Combined Use of Chemotherapy and Radiotherapy with PD-1 Inhibitor, Pembrolizumab, in Advanced Cervical Cancer: A Case Report

16 Spatial analysis identifies DC niches as predictors of pembrolizumab therapy in head and neck squamous cell cancer.

17 Unconventional success: Achieving long-term remission with pembrolizumab in recurrent high-grade endometrial carcinosarcoma.

18 Case Report | Pembrolizumab in the Management of Chemorefractory Gestational Choriocarcinoma: Report of Two Cases.